![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Advertisement
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
Persons > All
Find below all kinds of persons.Total search results: 6904 | Ordered by Person (ascending)
1 2 3 ... 16 17 18 ... 68 69 70 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Fiebig, Heinz-Herbert (Oncotest GmbH 201108 Managing Director) | Managing Director | Charles River (Group) | Germany |
| Fiedler, Ulrike (Coral BioNet 2000– Managing Director of Scil Proteins) | Managing Director | UV-Cap (Group) | Germany |
| Fiehn, Hendrik (GeSiM 200809) | Sales Manager / Marketing Manager | GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH | Germany |
| Field, Richard (CCS Cell Culture Service 201006 COO North America) | Regional manager | Evotec (Group) | United States (USA) |
| Fietz, Carsten (c-LEcta GmbH 201509– Head Finance + Administration before CFO) | Financial Manager (CFO, Financial Director, etc.) | c-LEcta GmbH | Germany |
| Figulla, Laura (Coramaze Technologies 201401– Managing Director + Co-founder) | Managing Director | Coramaze Technologies GmbH | Germany |
| Filerman, Marc (Germany (govt) 201906– CEO of German Accelerator Life Sciences before Secora + MGH) | Cluster Manager | Germany (govt) | United States (USA) |
| Filliol, Olivier (Mettler Toledo 199801– CEO) | Chief Executive Officer (CEO) | Mettler-Toledo (Group) | Switzerland |
| Finan, Peter (Epidarex Capital 2014– Venture Partner + Karus Therapeutics 201410– Head of Biology before Novartis) | Venture Partner | Karus Therapeutics Ltd. | United Kingdom (GB) |
| Finbow, Anthony (Eagle Genomics 201501– CEO before Executive Chairman) | Chief Executive Officer (CEO) | Eagle Genomics Ltd. | United Kingdom (GB) |
| Fink, Klaus (Eppendorf 2006 CEO joined 1989) | Chief Executive Officer (CEO) | Eppendorf (Group) | Germany |
| Fink, Thomas (Portus Corporate Finance 200804 Managing Director + CCM 200804 Managing Director) | Managing Director | CCM Columbus Capital Management GmbH | Germany |
| Finkbeiner, Petra (PANATecs 201003) | Sales Manager / Marketing Manager | Zukunftsfonds Heilbronn (Group) | Germany |
| Finke, Gandolf (Fosanis GmbH 201908 Managing Director + Co-Founder) | Managing Director | Fosanis GmbH | Germany |
| Firouz, Fereydoun (EMD Serono 200804 CEO) | Chief Executive Officer (CEO) | Merck (DE) (Group) | United States (USA) |
| Fisch, Igor (Selexis 201008 CEO + co-founder) | Chief Executive Officer (CEO) | JSR Corporation (Group) | Switzerland |
| Fischer, Achim (200407– Gentana) | n. a. | Gentana GmbH | Germany |
| Fischer, Benjamin (Hamburg (govt) 201707 Program Adivsor Innovation at IFB Hamburg) | n. a. | Hamburg (govt region) | Germany |
| Fischer, Bernd (Univ Lübeck 1996– Professor Mathematics + Fraunhofer MEVIS Lübeck 201004– Head) | Professor | University of Lübeck (Universität zu Lübeck, UzL) | Germany |
| Fischer, Bernhard (Apeptico 200903 CEO) | Chief Executive Officer (CEO) | Apeptico Forschung und Entwicklung GmbH | Austria |
| Fischer, Florian (MedVenture Partners 201305 Managing Director + Affimed CFO 201510) | Managing Director | MedVenture Partners GmbH | Germany |
| Fischer, Gunter S. (Max Planck 199606–200907– founding Director Research Unit for Enzymology Protein Folding Halle) | Professor | Max Planck Society for the Advancement of Science | Germany |
| Fischer, Hartmut (A&M Labor 201201 Managing Director) | Managing Director | A&M Labor für Analytik und Metabolismusforschung Service Gmb | |
| Fischer, Heinrich (Tecan 200702– Board Member before Saurer) | Board member | Tecan (Group) | Switzerland |
| Fischer, Karsten (Memo Therapeutics 201806– CEO before BioMedPartners + WestLB) | Chief Executive Officer (CEO) | BioMedPartners (Group) | Switzerland |
| Fischer, Markus (PolyQuant 201306 Managing Director + Entelechon GmbH 200709 Managing Director) | Managing Director | PolyQuant GmbH | Germany |
| Fischer, Michael (Univ Kiel 200505) | n. a. | University of Kiel (Christian-Albrechts-Universität, CAU) | Germany |
| Fischer, Rainer (IUCT 1998) | n. a. | Fraunhofer (Group) | Germany |
| Fischer, Robert (Omeicos Therapeutics GmbH 201312 Managing Director (CSO)) | Managing Director | Omeicos (Group) | Germany |
| Fischer, Stefan (Algiax 201104– CFO before NewLab BioQuality 200201– CFO) | Chief Financial Officer (CFO) | Algiax Pharmaceuticals GmbH | Germany |
| Fischer, Stefan (TVM 201603 General Partner + CFO) | General Partner (venture partner) | TVM (Group) | Germany |
| Fischer, Stephan (MAB Discovery GmbH 201209 Managing Director + Founder) | Managing Director | MAB Discovery GmbH | Germany |
| Fischer, Thomas (Eucodis 200912– CEO) | Chief Executive Officer (CEO) | Eucodis Bioscience (Group) | Austria |
| Fischer, Wolfgang (Affimed 201709– COO before Sandoz Biopharmaceuticals + Novartis) | Chief Operating Officer (COO) | Affimed (Group) | Germany |
| Fischer, Wolfgang H. (Salk Institute 201107 Staff Scientist + Head Mass Spec Core Facilty) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | Salk Institute for Biological Studies, The | United States (USA) |
| Fischer-Colbrie, Mark (Labcyte 201109 CEO) | Chief Executive Officer (CEO) | Danaher (Group) | United States (USA) |
| Fischer-Knuppertz, Wulf (Biocrates 201306–201909 CEO before Fisher Scientific + Roche Diagnostics RESIGNED 9/19) | Chief Executive Officer (CEO) | Biocrates (Group) | Austria |
| Fisher, Valeria (Trophic Communications 201906) | Public Relations Manager / Investor Relations Manager | Trophic Communications GmbH | Germany |
| Fisherman, Jason (C4 Therapeutics 201601– CEO before Synthesis Capital + Advent International) | Chief Executive Officer (CEO) | C4 Therapeutics Inc. (C4T) | United States (USA) |
| Fishman, Mark (Novartis Institutes of BioMedical Research 200509 President) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Switzerland |
| Fitzgerald, Daniel (Geneva Biotech 201711 CEO) | Chief Executive Officer (CEO) | Geneva Biotech (CH) | Switzerland |
| FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT) | Chief Executive Officer (CEO) | F-Star (Group) | Austria |
| FitzGerald, Peter (Randox Laboratories 200710 Managing Director) | Managing Director | Randox (Group) | United Kingdom (GB) |
| Fitzpatrick, David (Max Planck 201212– Scientific Director + CEO of MPFI) | President/Director/Head Business Group/Unit/Division | Max Planck Society for the Advancement of Science | United States (USA) |
| Flach, Jürgen (Sirion Biotech 201106 Managing Director CEO) | Chief Executive Officer (CEO) | Sirion Biotech (Group) | Germany |
| Flad, Thomas (PANATecs 201104 Head Technical Sales before 200512 Managing Director) | Sales Manager / Marketing Manager | Zukunftsfonds Heilbronn (Group) | Germany |
| Flade, Isabell (CeMeT GmbH 201407– Managing Director) | Managing Director | CeMeT GmbH – Center for Metagenomics | Germany |
| Fladrich, Mark (Grünenthal 201709– CCO before AstraZeneca) | Chief Commercial Officer (CCO) | Grünenthal (Group) | Germany |
| Flamm, Robert (Ruth Group 201612) | Public Relations Manager / Investor Relations Manager | Ruth Group, The (TRG) | United States (USA) |
| Flatman, Steve (Lonza 201101 Head Mammalian Development Services) | Research & Development Manager | Lonza Group (Group) | Switzerland |
| Fleck, Roman (Index Ventures 2006– Principal at Geneva office before Boehringer Ingelheim) | Principal (venture capital) | Index Ventures | Switzerland |
| Fleck, Stephan (Whatman 200711– before Bayer) | n. a. | General Electric (Group) | United Kingdom (GB) |
| Fleckenstein, Tamara (Elementar 201701 Event + External Communications Manager) | Public Relations Manager / Investor Relations Manager | Elementar (Group) | Germany |
| Fleig, Thomas (Valerius Bioharma 201805 CFO before Ernst & Young) | Chief Financial Officer (CFO) | Valerius Biopharma AG | Switzerland |
| Fleming, Bill (Oxitec 201704 CFO joined 2010 before Bayer + OBN 201704– Board Member) | Chief Financial Officer (CFO) | Intrexon (Group) | United Kingdom (GB) |
| Flenker, Ulrich (German Sport University 200804) | n. a. | Deutsche Sporthochschule Köln | Germany |
| Flensberg, Mikael (CLC bio 201304 Director Global Partner Relations) | Business Development Manager / Strategy Manager | Qiagen (Group) | Denmark |
| Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono) | Chief Financial Officer (CFO) | Novimmune S.A. | Switzerland |
| Fließbach, Holger (Alopex 200507– Managing Director) | Managing Director | Alopex GmbH | Germany |
| Flintholm Jørgensen, Keld (Lundbeck 201904– EVP + CBO before Roche Global Head of Strategic Partnering) | Chief Business Officer (CBO) | Lundbeck (Group) | Denmark |
| Flon, Aude (Sud de France 201111 Project Manager Multi-industrial Sector) | Administrative Officer (personnel) | Sud de France Développement | France |
| Flores, Lalo (Century Therapeutics 201907 CEO) | Chief Executive Officer (CEO) | Century Therapeutics (US) | United States (USA) |
| Floß, Georg (Biotest 201301– promoted COO joined Biotest 2/08) | Chief Operating Officer (COO) | Creat (Group) | Germany |
| Flückiger-Mangual, Stefanie (201809 CEO + Co-Founder) | Chief Executive Officer (CEO) | Tolremo Therapeutics AG | Switzerland |
| Focant, Jean-François (Univ Liège 201710 Prof + Director of OBiAChem) | Professor | University of Liège, Organic and Biological Analytical Chemistry Laboratory (OBiAChem) | Belgium |
| Foidart, Marc (Épimède 201711 Investment Manager) | Investment Manager | Noshaq (BE) | Belgium |
| Fontoura, Alexandre (SGS 201610 Business Manager at SGS Brazil) | Business Development Manager / Strategy Manager | SGS (Group) | Brazil |
| Foos, Christian (Berlin Capital Fund 200504) | n. a. | Triginta Capital (Group) | Germany |
| Forer, Michael (Celtic Therapeutics 201207 CEO of ADC Therapeutics until 6/15 + Partner in Celtic Therapeutics) | Chief Executive Officer (CEO) | ADC Therapeutics (Group) | Switzerland |
| Formela, Jean-François (Atlas Venture 201205 Partner joined 1993 before Schering-Plough) | Partner (venture partner) | Atlas Venture (Group) | United States (USA) |
| Fornaroli, Micol (Bracco 201710 Chief Strategy Officer at Bracco Imaging SpA) | Business Development Manager / Strategy Manager | Bracco (Group) | Italy |
| Forrest, Rosanna (Instinctif Partners 201603) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Forsberg, Erik (Uppsala BIO 201109 Managing Director) | Managing Director | Uppsala BIO | Sweden |
| Forster, Eliot (F-Star 201810– CEO before Immunocore + Creabilis + Solace Pharmaceuticals + Pfizer + GSK) | Chief Executive Officer (CEO) | F-Star (Group) | United Kingdom (GB) |
| Forster, Vincent (Versantis AG 201704 CEO + Co-Founder) | Chief Executive Officer (CEO) | Versantis AG | Switzerland |
| Foster, John (Owl Biomedical Inc 201404 President) | President/Director/Head Business Group/Unit/Division | Miltenyi Biotec (Group) | United States (USA) |
| Fotev, Zisi (Cenix BioScience 200502 CBO) | Chief Business Officer (CBO) | Cenix BioScience (Group) | Germany |
| Fotin-Mleczek, Mariola (CureVac 201710 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | CureVac (Group) | Germany |
| Foulger, Paul (EKF Diagnostics 201307– Interim Finance Director before Company Secretary) | Chief Financial Officer (CFO) | EKF Diagnostics (Group) | United Kingdom (GB) |
| Fouquet, Gerhard (Univ Kiel 201201 President + Professor) | President/Director/Head Business Group/Unit/Division | University of Kiel (Christian-Albrechts-Universität, CAU) | Germany |
| Fournier, Jennifer (Waters 201902 Director Product Marketing Chemistry Group) | Sales Manager / Marketing Manager | Waters (Group) | United States (USA) |
| Fowler, Sanna (Lonza 201809 Head PR Lonza Pharma & Biotech) | Public Relations Manager / Investor Relations Manager | Lonza Group (Group) | Switzerland |
| Fowles, Richard (United Kingdom (govt) 201010 Category Manager at RCUK SSC Ltd) | n. a. | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Foy, Shaun (CRISPR Therapeutics 201404 CFO + Co-Founder + ERS Genomics CEO + Co-Founder before Nomura Phase4 Ventures) | Chief Financial Officer (CFO) | CRISPR Therapeutics (Group) | Switzerland |
| Frahm, Thomas (Norgenta 201211 Manager Marketing + PR) | Cluster Manager | Hamburg (govt region) | Germany |
| Francis, Richard (Novartis 201404– Divison Head of Sandoz before Biogen Idec + Sanofi + Wyeth) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Germany |
| Franco, Nicholas (Actelion 201106 Chief Business Developm Officer before Axcan Pharma Paris before Novartis Pharma AG) | Business Development Manager / Strategy Manager | Novartis (Group) | Switzerland |
| Francoise, Jacques (CSM Instruments –201311 General Manager) | General Manager (management) | Anton Paar (Group) | Switzerland |
| Frank, Gert (Geratherm 201507 CEO) | Chief Executive Officer (CEO) | Geratherm (Group) | Germany |
| Frank, Hans-Georg (AplaGen 200810 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | AplaGen GmbH | Germany |
| Frank, Peter (ScanBalt 201105 General Sectretary) | Administrative Officer (personnel) | ScanBalt Network (Scanbalt MTÜ) | Estonia |
| Franken, Sebastian (Univ Bonn 201101 IBMB Team Leader Mass Spectrometry) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) | Germany |
| Frankenne, Günter (november 200611– ) | n. a. | November (Group) | Germany |
| Franksson, Olof (HotSwap 201102 CEO) | Chief Executive Officer (CEO) | HotSwap (Group) | Sweden |
| Frantsits, Werner (Sanochemia 201208 CEO) | Chief Executive Officer (CEO) | Sanochemia (Group) | Austria |
| Franz, Christoph (Roche 201403– Board Chairman before Lufthansa CEO) | Board member, non-executive | Roche (Group) | Switzerland |
| Franz, Oliver (Eppendorf 200804 Executive Director Portfolio Management PCR + Automation) | Product Manager (personnel) | Eppendorf (Group) | Germany |
| Franzen, Jochen (Bruker Daltonik) | Company Founder | Bruker Corporation (Group) | Germany |
| Frasch, Markus (AppliChem 200904 Managing Director) | Managing Director | Illinois Tool Works (ITW) (Group) | Germany |
| Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) | Professor | University of London | United Kingdom (GB) |
1 2 3 ... 16 17 18 ... 68 69 70
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
